Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 3
2007 1
2009 1
2011 3
2012 3
2013 3
2014 2
2015 4
2016 2
2017 2
2018 2
2019 2
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for jeonghee cho
Search for Keonhee Cho instead (1 results)
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.
Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M, Sivachenko A, Sougnez C, Auclair D, Lawrence MS, Stojanov P, Cibulskis K, Choi K, de Waal L, Sharifnia T, Brooks A, Greulich H, Banerji S, Zander T, Seidel D, Leenders F, Ansén S, Ludwig C, Engel-Riedel W, Stoelben E, Wolf J, Goparju C, Thompson K, Winckler W, Kwiatkowski D, Johnson BE, Jänne PA, Miller VA, Pao W, Travis WD, Pass HI, Gabriel SB, Lander ES, Thomas RK, Garraway LA, Getz G, Meyerson M. Imielinski M, et al. Among authors: cho j. Cell. 2012 Sep 14;150(6):1107-20. doi: 10.1016/j.cell.2012.08.029. Cell. 2012. PMID: 22980975 Free PMC article.
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2.
Greulich H, Kaplan B, Mertins P, Chen TH, Tanaka KE, Yun CH, Zhang X, Lee SH, Cho J, Ambrogio L, Liao R, Imielinski M, Banerji S, Berger AH, Lawrence MS, Zhang J, Pho NH, Walker SR, Winckler W, Getz G, Frank D, Hahn WC, Eck MJ, Mani DR, Jaffe JD, Carr SA, Wong KK, Meyerson M. Greulich H, et al. Among authors: cho j. Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14476-81. doi: 10.1073/pnas.1203201109. Epub 2012 Aug 20. Proc Natl Acad Sci U S A. 2012. PMID: 22908275 Free PMC article.
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.
Hammerman PS, Sos ML, Ramos AH, Xu C, Dutt A, Zhou W, Brace LE, Woods BA, Lin W, Zhang J, Deng X, Lim SM, Heynck S, Peifer M, Simard JR, Lawrence MS, Onofrio RC, Salvesen HB, Seidel D, Zander T, Heuckmann JM, Soltermann A, Moch H, Koker M, Leenders F, Gabler F, Querings S, Ansén S, Brambilla E, Brambilla C, Lorimier P, Brustugun OT, Helland A, Petersen I, Clement JH, Groen H, Timens W, Sietsma H, Stoelben E, Wolf J, Beer DG, Tsao MS, Hanna M, Hatton C, Eck MJ, Janne PA, Johnson BE, Winckler W, Greulich H, Bass AJ, Cho J, Rauh D, Gray NS, Wong KK, Haura EB, Thomas RK, Meyerson M. Hammerman PS, et al. Among authors: cho j. Cancer Discov. 2011 Jun;1(1):78-89. doi: 10.1158/2159-8274.CD-11-0005. Cancer Discov. 2011. PMID: 22328973 Free PMC article.
Mechanistic insights into differential requirement of receptor dimerization for oncogenic activation of mutant EGFR and its clinical perspective.
Cho J. Cho J. BMB Rep. 2020 Mar;53(3):133-141. doi: 10.5483/BMBRep.2020.53.3.025. BMB Rep. 2020. PMID: 32172728 Free PMC article. Review.
Colorectal adenocarcinoma-derived EGFR mutants are oncogenic and sensitive to EGFR-targeted monoclonal antibodies, cetuximab and panitumumab.
Kim N, Cho D, Kim H, Kim S, Cha YJ, Greulich H, Bass A, Cho HS, Cho J. Kim N, et al. Among authors: cho j. Int J Cancer. 2020 Apr 15;146(8):2194-2200. doi: 10.1002/ijc.32499. Epub 2019 Jul 9. Int J Cancer. 2020. PMID: 31290142
Activation of CXCL12-CXCR4 signalling induces conversion of immortalised embryonic kidney cells into cancer stem-like cells.
Oh SI, Jeong H, Park HS, Choi KA, Hwang I, Lee J, Cho J, Hong S. Oh SI, et al. Among authors: cho j. Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):1303-1313. doi: 10.1080/21691401.2020.1841783. Artif Cells Nanomed Biotechnol. 2020. PMID: 33150801
Whole Transcriptome Analysis Identifies TNS4 as a Key Effector of Cetuximab and a Regulator of the Oncogenic Activity of KRAS Mutant Colorectal Cancer Cell Lines.
Kim S, Kim N, Kang K, Kim W, Won J, Cho J. Kim S, et al. Among authors: cho j. Cells. 2019 Aug 12;8(8):878. doi: 10.3390/cells8080878. Cells. 2019. PMID: 31409052 Free PMC article.
Autophosphorylation of the carboxyl-terminal domain is not required for oncogenic transformation by lung-cancer derived EGFR mutants.
Cho J, Kim S, Du J, Meyerson M. Cho J, et al. Int J Cancer. 2018 Aug 1;143(3):679-685. doi: 10.1002/ijc.31332. Epub 2018 Mar 5. Int J Cancer. 2018. PMID: 29464683 Free PMC article.
MerTK is a novel therapeutic target in gastric cancer.
Yi JH, Jang J, Cho J, Do IG, Hong M, Kim ST, Kim KM, Lee S, Park SH, Park JO, Park YS, Kang WK, Lim HY, Lee J. Yi JH, et al. Among authors: cho j. Oncotarget. 2015 Apr 20;8(57):96656-96667. doi: 10.18632/oncotarget.3750. eCollection 2017 Nov 14. Oncotarget. 2015. PMID: 29228560 Free PMC article.
Early emergence of de novo EGFR T790M gatekeeper mutations during erlotinib treatment in PC9 non-small cell lung cancer cells.
Kim S, Park AK, Cho J. Kim S, et al. Among authors: cho j. Biochem Biophys Res Commun. 2018 Sep 5;503(2):710-714. doi: 10.1016/j.bbrc.2018.06.065. Epub 2018 Jun 27. Biochem Biophys Res Commun. 2018. PMID: 29909007
31 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback